The Gabelli Go Anywhere Trust GGO
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 25.06M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 1.20%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.14
- Inst. own
- 2.17%
- Dividend
- 0.20
- Ex-div date
- Sep 14, 2021
- 50-d avg
- 16.73
- 200-d avg
- 16.21
- 1y target
- 0.00
Key statistics
- Market cap
- 25.06M
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 1.20%
- Payout ratio
- 2.66%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Shares outstanding
- 1.55M
- Short % of float
- 0.00%
- 50-day average
- 16.73
- 200-day average
- 16.21
Analyst view
Consensus: none
Next earnings
Consensus EPS estimate 0.00.
About The Gabelli Go Anywhere Trust
The Gabelli Go Anywhere Trust is a closed ended balanced mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in public equity and fixed income markets of the United States. The fund makes its investments in the stocks of companies operating across diversified sectors. It primarily invests in common stock, preferred stock, convertible or exchangeable securities, depositary receipts, and warrants. The fund also invests in debt securities. It benchmarks the performance of its portfolio against the S&P 500 Index. The fund conducts in-house research to make its investments. The Gabelli Go Anywhere Trust was formed on November 2, 2016, and is domiciled in the United States.
- Sector
- Financial Services
- Industry
- Asset Management
- Country
- United States
News
- Savara Presented New Data Showing Molgramostim Inhalation Solution (Molgramostim) Treatment Effects in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Patients with Mild Diffusion Impairment
- Galleon Gold Announces Retirement of Director
- Galleon Gold's 2026 Drilling Confirms Down-Dip Continuity at Zone #9 and Expands South Zone Footprint
- Galleon Gold Announces Results of Annual and Special Meeting of Shareholders
- Galleon Gold Announces Issuance of Shares for Interest Payment on Convertible Debentures
- Galleon Gold Announces Interest Payment on Convertible Debentures
- Galleon Gold Amends Credit Agreement with Pan American Silver
- Galleon Gold Provides Corporate and Operational Update
- Galleon Gold's 2025 Year in Review and Execution Roadmap for 2026
- Galleon Gold Announces Grant of Stock Options
Your note
Sign in to keep a note on GGO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| GABELLI MARIO JOSEPH | Director | Sale | Jun 6, 2021 | 0 |
| MELARKEY MICHAEL J | Director | Purchase | Sep 5, 2016 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Gabelli & Co. Investment Advisers, Inc. | 7.21% | 111,487 | 1.34M | Dec 30, 2020 |
| Gamco Investors Inc | 6.66% | 103,104 | 1.24M | Dec 30, 2020 |
| Blue Bell Private Wealth Management, LLC | 0.15% | 2,253 | 27.04K | Dec 30, 2020 |
| UBS Group AG | 0.09% | 1,324 | 15.89K | Dec 30, 2020 |